These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 33578250)
1. Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion. Xie L; Wang L; Guan R; Ji L; Chao H J Inorg Biochem; 2021 Apr; 217():111380. PubMed ID: 33578250 [TBL] [Abstract][Full Text] [Related]
2. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601 [TBL] [Abstract][Full Text] [Related]
3. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts. Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920 [TBL] [Abstract][Full Text] [Related]
4. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells. Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350 [TBL] [Abstract][Full Text] [Related]
5. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity. Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112 [TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest. Li YL; Zhu XM; Chen NF; Chen ST; Yang Y; Liang H; Chen ZF Eur J Med Chem; 2022 Jun; 236():114312. PubMed ID: 35421660 [TBL] [Abstract][Full Text] [Related]
7. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets. Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells. Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F Spectrochim Acta A Mol Biomol Spectrosc; 2019 Sep; 220():117132. PubMed ID: 31146211 [TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition. Zhang GD; Wang MM; Su Y; Fang H; Xue XL; Liu HK; Su Z J Inorg Biochem; 2024 Jul; 256():112574. PubMed ID: 38677004 [TBL] [Abstract][Full Text] [Related]
11. Visible-Light-Responsive Novel Ru(II)-Metallo-Antibiotics with Potential Antibiofilm and Antibacterial Activity. Mandal AA; Upadhyay A; Mandal A; Nayak M; K MS; Mukherjee S; Banerjee S ACS Appl Mater Interfaces; 2024 Jun; 16(22):28118-28133. PubMed ID: 38783713 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes. Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands. Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859 [TBL] [Abstract][Full Text] [Related]
14. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes. Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162 [TBL] [Abstract][Full Text] [Related]
15. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells. Fayad C; Audi H; Khnayzer RS; Daher CF J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954 [TBL] [Abstract][Full Text] [Related]
16. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase. Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557 [TBL] [Abstract][Full Text] [Related]
19. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway. Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891 [TBL] [Abstract][Full Text] [Related]
20. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction. Ribeiro GH; Guedes APM; de Oliveira TD; de Correia CRSTB; Colina-Vegas L; Lima MA; Nóbrega JA; Cominetti MR; Rocha FV; Ferreira AG; Castellano EE; Teixeira FR; Batista AA Inorg Chem; 2020 Oct; 59(20):15004-15018. PubMed ID: 32997499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]